Introduction The widespread adoption of high-throughput sequencing (HTS) in the past decade has transformed biomedical research and clinical practice [1, 2]. These technologies have enabled large-scale identification of molecular alterations linked to disease, leading to the discovery of numerous genes responsible for rare diseases (RD), a deeper understanding of the genomic complexity of major cancer types and pathogen recognition at unprecedented scale [3-5].
Anna Lindstrand
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Anna
Contact Anna, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack